File SF5046 ("Eliminates Minnesota prescription drug affordability council") is before the Minnesota Legislature and has not been decided. Latest step (April 16, 2026): Comm report: To pass and re-referred to.
Minnesota file SF5046, before the Minnesota Legislature. Still to be decided as of 2026-04-16.
State loses dedicated drug affordability analysis and reporting Minnesota will no longer have an official council to study prescription drug prices, track affordability trends, or recommend policy solutions to the legislature.
Reduces data collection on drug cost burden in state Without the council's monitoring and reporting, state policymakers and insurers lose a centralized source of information about which drugs are becoming unaffordable and which populations are most affected.
Prescription Drug Affordability Advisory Council elimination
Read the official record for SF5046
See everything up for a vote · This week in Minnesota · See what we have filed with the clerk